EUVIMEDEUVIMED entdecken
Crossref

Survival Outcomes and Recurrence Patterns Following Focal High-intensity Focused Ultrasound Treatment for Localized Prostate Cancer: Insights on Patient Selection and Lessons Learned

Bruno Nahar, Tarek Ajami, Adam Williams, Nachiketh Soodana Prakash, Archan Khandekar, Pedro F S Freitas, Ankur Malpani, Jonathan T Ryan, Keerthana Sureshkumar, Chad R Ritch, Mark L Gonzalgo, Sanoj Punnen und 1 weitere

European Urology Focus · 2025

DOI: 10.1016/j.euf.2024.11.005 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Urology Focus, 2025. Verfasst von Bruno Nahar und 12 weiteren Autor:innen. Beteiligte Einrichtung: Desai Sethi Urology Institute, Miller School of Medicine, University of Miami, Miami, FL, USA. Electronic address: brunonahar@miami.edu. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Neoplasm Recurrence, Local, Patient Selection, Ultrasound, High-Intensity Focused, Transrectal. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 17 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND AND OBJECTIVE: Focal therapy is increasingly being used as a treatment for localized prostate cancer (PC). Our aim was to evaluate oncological outcomes, recurrence patterns, and survival after high-intensity focused ultrasound (HIFU), to discuss the lessons learned from our experience, and to propose strategies to enhance patient selection for HIFU treatment. METHODS: Between 2016 and 2023, 113 patients underwent focal HIFU treatment for PC. Follow-up included prostate-specific antigen (PSA) measurement every 3 mo, magnetic resonance imaging, and a control biopsy performed at 6 or 12 mo. Recurrence was categorized on the basis of location (infield or out-of-field) and Gleason grade group (clinically significant [CS] vs non-CS) with stratification by National Comprehensive Cancer Network risk groups. Kaplan-Meier curves were used to analyze survival outcomes, recurrence rates, and the need for retreatment. KEY FINDINGS AND LIMITATIONS: Median follow-up was 29 mo and 92 patients (81%) had PSA follow-up for at least 12 mo. Local recurrence was observed in 34 patients (37%), which was CS in 16 (17%). The CS recurrence-free survival rate at 3 yr was worse for subgroups with high-risk or unfavorable intermediate-risk disease in comparison to the group with favorable intermediate-risk PC (40% and 53% vs 85%; log-rank p < 0.01), with a higher rate of out-of-field recurrence in the high-risk group. The Kaplan-Meier retreatment-free survival rate estimate was 71% at 3 yr. Sixteen patients (17%) underwent salvage local treatment. Study limitations include the small cohort size and relatively short follow-up. CONCLUSIONS AND CLINICAL IMPLICATIONS: HIFU is a promising alternative for localized PC in well-selected patients. However, patients with high-risk or unfavorable intermediate-risk PC are more likely to experience treatment failure. PATIENT SUMMARY: We examined cancer control outcomes after high-intensity focused ultrasound for localized prostate cancer. We found that the rate of cancer recurrence was higher for patients with higher-risk disease. However, this treatment is a feasible and acceptable option for patients with intermediate risk.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prostatic NeoplasmsNeoplasm Recurrence, LocalPatient SelectionUltrasound, High-Intensity Focused, TransrectalHigh-Intensity Focused Ultrasound AblationHumansMaleAgedMiddle AgedTreatment OutcomeProstate-Specific AntigenSurvival Rate

Stichwörter der Autor:innen

Focal therapyHigh-intensity focused ultrasoundProstate cancer

Substanzen

Prostate-Specific Antigen

Autor:innen und Institutionen

  • Desai Sethi Urology Institute, Miller School of Medicine, University of Miami, Miami, FL, USA. Electronic address: brunonahar@miami.edu.
  • Desai Sethi Urology Institute, Miller School of Medicine, University of Miami, Miami, FL, USA; Department of Urology, Hospital Clinic de Barcelona, University of Barcelona, Barcelona, Spain.
  • Desai Sethi Urology Institute, Miller School of Medicine, University of Miami, Miami, FL, USA.

Zitieren

APA

Nahar, B., Ajami, T., Williams, A., Soodana Prakash, N., Khandekar, A., Freitas, P. F. S., Malpani, A., Ryan, J. T., Sureshkumar, K., Ritch, C. R., Gonzalgo, M. L., Punnen, S., & Parekh, D. J. (2025). Survival Outcomes and Recurrence Patterns Following Focal High-intensity Focused Ultrasound Treatment for Localized Prostate Cancer: Insights on Patient Selection and Lessons Learned. European Urology Focus. https://doi.org/10.1016/j.euf.2024.11.005

Vancouver

Nahar B, Ajami T, Williams A, Soodana Prakash N, Khandekar A, Freitas PFS, et al. Survival Outcomes and Recurrence Patterns Following Focal High-intensity Focused Ultrasound Treatment for Localized Prostate Cancer: Insights on Patient Selection and Lessons Learned. European Urology Focus. 2025. doi:10.1016/j.euf.2024.11.005

BibTeX
@article{Nahar2025,
  author = {Nahar, Bruno and Ajami, Tarek and Williams, Adam and Soodana Prakash, Nachiketh and Khandekar, Archan and Freitas, Pedro F S and Malpani, Ankur and Ryan, Jonathan T and Sureshkumar, Keerthana and Ritch, Chad R and Gonzalgo, Mark L and Punnen, Sanoj and Parekh, Dipen J},
  title = {Survival Outcomes and Recurrence Patterns Following Focal High-intensity Focused Ultrasound Treatment for Localized Prostate Cancer: Insights on Patient Selection and Lessons Learned},
  journal = {European Urology Focus},
  year = {2025},
  doi = {10.1016/j.euf.2024.11.005}
}
Kostenlos starten →